Basic Information
RNALocate ID: | RLID:11002492 |
RNA Symbol: | hsa-miR-374a-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-374a-5p |
RNA ID: | miRBase:MIMAT0000727 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002032 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002033 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002034 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002035 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:01002036 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11002489 | Exosome | Serum | 18589210 |
RLID:11002490 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002491 | Exosome | Brain tissue | 23382797 |
RLID:11002493 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002494 | Exosome | Plasma|Serum | 24683445 |
RLID:11002495 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000120 | Exosome | Seminal fluid | |
RLID-D:11000415 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-374a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-45519 |
MNDR | hsa-miR-374a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-45520 |
MNDR | hsa-miR-374a-5p | Oral squamous cell carcinoma | MNDR-E-MI-45521 |
MNDR | hsa-miR-374a-5p | Ovarian clear cell carcinoma | MNDR-E-MI-45522 |
MNDR | hsa-miR-374a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-45523 |
MNDR | hsa-miR-374a-5p | Lymphoma | MNDR-E-MI-45524 |
MNDR | hsa-miR-374a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-45525 |
MNDR | hsa-miR-374a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-45526 |
MNDR | hsa-miR-374a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-45527 |
MNDR | hsa-miR-374a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-45528 |
MNDR | hsa-miR-374a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-45529 |
MNDR | hsa-miR-374a-5p | Breast cancer luminal | MNDR-E-MI-45530 |
MNDR | hsa-miR-374a-5p | Niemann-pick disease type c | MNDR-E-MI-45531 |
MNDR | hsa-miR-374a-5p | Prostate cancer | MNDR-E-MI-45532 |
MNDR | hsa-miR-374a-5p | Gastric cancer | MNDR-E-MI-45533 |
MNDR | hsa-miR-374a-5p | Gastric lymphoma | MNDR-E-MI-45534 |
MNDR | hsa-miR-374a-5p | Alzheimer disease | MNDR-E-MI-45535 |
MNDR | hsa-miR-374a-5p | Intracranial aneurysm | MNDR-E-MI-45536 |
MNDR | hsa-miR-374a-5p | Esophageal carcinoma | MNDR-E-MI-45537 |
MNDR | hsa-miR-374a-5p | Dysautonomia familial | MNDR-E-MI-45538 |
MNDR | hsa-miR-374a-5p | Cardiovascular disease | MNDR-E-MI-45539 |
MNDR | hsa-miR-374a-5p | Parkinson disease | MNDR-E-MI-45540 |
MNDR | hsa-miR-374a-5p | Machado-joseph disease | MNDR-E-MI-45541 |
MNDR | hsa-miR-374a-5p | Niemann-pick disease | MNDR-E-MI-45542 |
MNDR | hsa-miR-374a-5p | Basal-like breast cancer | MNDR-E-MI-45543 |
MNDR | hsa-miR-374a-5p | Pancreatic cancer | MNDR-E-MI-45544 |
MNDR | hsa-miR-374a-5p | Melanoma | MNDR-E-MI-45545 |
MNDR | hsa-miR-374a-5p | Rectum adenocarcinoma | MNDR-E-MI-45546 |
MNDR | hsa-miR-374a-5p | Nephroblastoma | MNDR-E-MI-45547 |
MNDR | hsa-miR-374a-5p | Colon cancer | MNDR-E-MI-45548 |
MNDR | hsa-miR-374a-5p | Hypoxia-ischemia brain | MNDR-E-MI-45549 |
MNDR | hsa-miR-374a-5p | Colon adenocarcinoma | MNDR-E-MI-45550 |
MNDR | hsa-miR-374a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-45551 |
MNDR | hsa-miR-374a-5p | Prostate adenocarcinoma | MNDR-E-MI-45552 |
MNDR | hsa-miR-374a-5p | Glioblastoma | MNDR-E-MI-45553 |
MNDR | hsa-miR-374a-5p | Glioma | MNDR-E-MI-45554 |
MNDR | hsa-miR-374a-5p | Oligodendroglioma | MNDR-E-MI-45555 |
MNDR | hsa-miR-374a-5p | Epilepsy temporal lobe | MNDR-E-MI-45556 |
MNDR | hsa-miR-374a-5p | Osteosarcoma | MNDR-E-MI-45557 |
MNDR | hsa-miR-374a-5p | Liposarcoma | MNDR-E-MI-45558 |
MNDR | hsa-miR-374a-5p | Meningioma | MNDR-E-MI-45559 |
MNDR | hsa-miR-374a-5p | Gastric adenocarcinoma | MNDR-E-MI-45560 |
MNDR | hsa-miR-374a-5p | Lung squamous cell carcinoma | MNDR-E-MI-45561 |
MNDR | hsa-miR-374a-5p | Lung adenocarcinoma | MNDR-E-MI-45562 |
MNDR | hsa-miR-374a-5p | Adrenocortical cancer | MNDR-E-MI-45563 |
MNDR | hsa-miR-374a-5p | Thyroid carcinoma | MNDR-E-MI-45564 |
MNDR | hsa-miR-374a-5p | Bladder urothelial carcinoma | MNDR-E-MI-45565 |
MNDR | hsa-miR-374a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-45566 |
MNDR | hsa-miR-374a-5p | Carcinoma renal cell | MNDR-E-MI-45567 |
MNDR | hsa-miR-374a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-45568 |
MNDR | hsa-miR-374a-5p | Renal clear cell carcinoma | MNDR-E-MI-45569 |
MNDR | hsa-miR-374a-5p | Cholangiocarcinoma | MNDR-E-MI-45570 |
MNDR | hsa-miR-374a-5p | Synovial sarcoma | MNDR-E-MI-45571 |
MNDR | hsa-miR-374a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-45572 |
MNDR | hsa-miR-374a-5p | Early hepatocellular carcinoma | MNDR-E-MI-45573 |
MNDR | hsa-miR-374a-5p | Embryonal cancer | MNDR-E-MI-45574 |
MNDR | hsa-miR-374a-5p | B-cell lymphoma | MNDR-E-MI-45575 |
MNDR | hsa-miR-374a-5p | Rheumatoid arthritis | MNDR-E-MI-45576 |
MNDR | hsa-miR-374a-5p | T-cell leukemia | MNDR-E-MI-45577 |
MNDR | hsa-miR-374a-5p | Retinoblastoma | MNDR-E-MI-45578 |
MNDR | hsa-miR-374a-5p | Barrett's adenocarcinoma | MNDR-E-MI-45579 |
MNDR | hsa-miR-374a-5p | Hodgkin lymphoma | MNDR-E-MI-45580 |
MNDR | hsa-miR-374a-5p | Burkitt lymphoma | MNDR-E-MI-45581 |
MNDR | hsa-miR-374a-5p | Psoriasis | MNDR-E-MI-45582 |
MNDR | hsa-miR-374a-5p | Acute myelocytic leukemia | MNDR-E-MI-45583 |
MNDR | hsa-miR-374a-5p | Colorectal cancer | MNDR-E-MI-45584 |
MNDR | hsa-miR-374a-5p | Nasopharynx carcinoma | MNDR-E-MI-45585 |
MNDR | hsa-miR-374a-5p | Multiple myeloma | MNDR-E-MI-45586 |
MNDR | hsa-miR-374a-5p | Ovarian epithelial cancer | MNDR-E-MI-45587 |
MNDR | hsa-miR-374a-5p | Nasopharyngeal cancer | MNDR-E-MI-45588 |
MNDR | hsa-miR-374a-5p | Epstein-barr virus infections | MNDR-E-MI-45589 |
MNDR | hsa-miR-374a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-45590 |
MNDR | hsa-miR-374a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-45591 |
MNDR | hsa-miR-374a-5p | Stroke lacunar | MNDR-E-MI-45592 |
MNDR | hsa-miR-374a-5p | Barrett's carcinogenesis | MNDR-E-MI-45593 |
MNDR | hsa-miR-374a-5p | High grade dysplastic nodule | MNDR-E-MI-45594 |
MNDR | hsa-miR-374a-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-45595 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ATM | Homo sapiens | RR00158102 |
TOP